top of page

California Governor Signs Bill To Break Psychedelics Research Logjam

  • Writer: Bob Marley
    Bob Marley
  • Jul 19, 2024
  • 3 min read

The governor of California has signed a bill into law that’s meant to streamline the processing of applications to study psychedelics and marijuana.

While advocates have experienced a series of setbacks in the push to provide legal access to certain psychedelics over the past several sessions, Gov. Gavin Newsom (D) approved the modest reform on Thursday, about two weeks after it cleared the legislature.

The legislation from Assemblymember Marie Waldron (R) is meant to help clear a logjam of psychedelics study applications overseen by the Research Advisory Panel of California (RAPC), which has almost 70 pending proposals.

The body hasn’t met since last August following a policy change that prevented it from holding closed-door meetings. Members decided to suspend their activities because they’re prohibited under existing law from publicly disclosing applicants’ trade secrets and other confidential information.

To resolve the issue, the legislation reauthorizes the panel to carry out their duties in closed-door meetings, freeing them up to process the backlog.

Under the newly enacted law, the panel will be directed to provide a report to lawmakers by January 1, 2026 providing an update on the backlog of applications, including the number reviewed and the number still yet to be reviewed, as of the report’s submission.

The signing of the legislation comes after another psychedelics bill was withdrawn by the sponsors last month due to a lack of support in a key Assembly committee. The “Heal Our Heroes Act” would have authorized a pilot program to provide psilocybin treatment to military veterans and former first responders.

The bill’s introduction came weeks after a Senate committee also effectively killed a broader bill that would have legalized psychedelic service centers where adults 21 and older could have accessed psilocybin, MDMA, mescaline and DMT in a supervised environment with trained facilitators.

It had been drafted in a way that was meant to be responsive to concerns voiced by the governor last year when he vetoed a broader proposal that included provisions to legalize low-level possession of substances such as psilocybin.

Instead, the revised bill would have provided regulated access to psychedelics in a facilitated setting, without removing criminal penalties for possession outside of that context. It did not lay out any specific qualifying medical conditions that a person would need to have in order to access the services.

Marijuana Moment is tracking more than 1,500 cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.—

Separately, a California campaign to put psilocybin legalization on the state’s November ballot recently announced that it did not secure enough signature to qualify in time for a deadline.

Another campaign filed and then abruptly withdrew an initiative to create a $5 billion state agency tasked with funding and promoting psychedelics research last year.

A third campaign also entered the mix late last year, proposing to legalize the possession and cultivation of substances like psilocybin, LSD, MDMA, DMT, ibogaine and mescaline. People could buy them for therapeutic use with a doctor’s recommendation. Advocates for that measure still have time to gather and turn in signatures.

The California Legislative Analyst’s Office (LAO) has since released its review of that proposal, outlining not only the plan’s policy implications but also its potential fiscal impacts on the state—which the report calls “various” and “uncertain.”

Some California municipalities, meanwhile, are pushing forward with reform on the local level. The city of Eureka, for example, adopted a resolution in October to decriminalize psychedelic plants and fungi and make enforcement of laws against personal use, cultivation and possession a low priority for police. It’s at least the fifth local jurisdiction in the state to embrace the policy change. Others include San FranciscoOaklandSanta Cruz and Arcata.

State Marijuana Regulators Push Feds To Explain How Rescheduling Will Impact Enforcement, Banking, Research And More

Photo elements courtesy of carlosemmaskype and Apollo.

Comments


Global SEO Keywords

marihuana, cannabis, cáñamo, CBD, aceite de CBD, bálsamo de CBD, marijuana, hemp, weed, CBD oil, CBD balm, canapa, erba, olio di CBD, balsamo CBD, chanvre, herbe, huile de CBD, baume CBD, Marihuana, Cannabis, Hanf, Gras, CBD Öl, CBD Balsam, maconha, cânhamo, erva, óleo de CBD, bálsamo CBD, hennep, wiet, CBD olie, CBD balsem, hampa, gräs, CBD olja, CBD balsam, hamp, græs, gress, CBD olje, hamppu, ruoho, CBD öljy, CBD balsami, konopie, konopie indyjskie, olej CBD, balsam CBD, konopí, CBD olej, CBD balzám, konope, CBD balzam, marihuána, kannabisz, kender, fű, CBD olaj, CBD balzsam, canabis, cânepă, iarbă, ulei CBD, марихуана, канабис, коноп, CBD масло, CBD балсам, μαριχουάνα, κάνναβη, χασίς, λάδι CBD, βάλσαμο CBD, kanabis, konoplja, trava, CBD ulje, CBD olje, kanapės, kanapės indinės, CBD aliejus, CBD balzamas, marihuāna, kaņepes, CBD eļļa, CBD balzams, marihuaana, kanep, CBD õli, CBD palsam, kannabis, qanneb, żejt CBD, balsam CBD, marijúna, hampur, CBD olía, CBD smyrsl

Disclaimer

Jacob Hooy CBD Lip Balm is free from parabens and artificial colorants and contains no toxins or heavy metals, supporting natural body care. Our products are not intended to diagnose, treat, cure, or prevent any disease, medical condition, or symptom. The information provided on this website is for informational purposes only and must not be considered medical advice, nor a substitute for professional diagnosis, treatment, or guidance provided by qualified physicians, healthcare professionals, or pharmaceutical specialists. Nothing on this website should be interpreted as a recommendation, prescription, or therapeutic claim.

Difresh Spain is an online retail store registered under IAE Group 652.3, specializing in the retail trade of perfumery, cosmetic products, and personal hygiene and care items. NIF: Y3526859-F. E-mail: info@cbdvending.eu - WhatsApp: +34662918154 - Factory adress: Calle Albardín 13, Nave B07, 50720, La cartuja baja, Zaragoza, España. All prices include VAT and free shipping across all European Union countries.

© 2026 - www.cbdvending.euPrivacy Policy

bottom of page